Aravive, Inc. Common Stock
ARAV
ARAV was delisted on the 26th of January, 2024.
38 hedge funds and large institutions have $10.2M invested in Aravive, Inc. Common Stock in 2018 Q4 according to their latest regulatory filings, with 6 funds opening new positions, 14 increasing their positions, 13 reducing their positions, and 17 closing their positions.
143% more call options, than puts
Call options by funds: $114K | Put options by funds: $47K
8% more repeat investments, than reductions
Existing positions increased: 14 | Existing positions reduced: 13
24% less funds holding
Funds holding: 50 → 38 (-12)
40% less capital invested
Capital invested by funds: $17M → $10.2M (-$6.8M)
65% less first-time investments, than exits
New positions opened: 6 | Existing positions closed: 17
Top Buyers
Top Sellers
| 1 |
Vanguard Group
Malvern,
Pennsylvania
|
-$384K |
| 2 |
Millennium Management
New York
|
-$296K |
| 3 |
Goldman Sachs
New York
|
-$274K |
| 4 |
Jacobs Levy Equity Management
Florham Park,
New Jersey
|
-$240K |
| 5 |
GCP
GSA Capital Partners
London,
United Kingdom
|
-$236K |
ARAV Hedge Fund Activity: Q4 2018 in Review
38 of the 4,488 institutional investors tracked by Wall St. Rank reported a position in Aravive, Inc. Common Stock (ARAV) for Q4 2018, worth a combined $10.2M — down 40% from $17M a quarter earlier.
Sellers outnumbered buyers: 17 funds closed out of ARAV and 6 opened new positions — a net loss of 11 holders — while 13 trimmed existing stakes and 14 added.
The largest buyer was New Leaf Venture Partners, adding an estimated $3.21M. The largest seller was Vanguard Group, cutting an estimated $384K.
- 38 institutional investors held Aravive, Inc. Common Stock (ARAV) as of Q4 2018, down from 50 in Q3 2018.
- Funds reported $10.2M of Aravive, Inc. Common Stock stock for Q4 2018, down 40% quarter-over-quarter.
- 6 funds opened new Aravive, Inc. Common Stock positions in Q4 2018 and 17 closed out, a net change of -11 holders.
- The largest Aravive, Inc. Common Stock buyer in Q4 2018 was New Leaf Venture Partners, an estimated $3.21M added.
- The largest Aravive, Inc. Common Stock seller in Q4 2018 was Vanguard Group, an estimated $384K sold.
Based on aggregated 13F filings for Q4 2018.